UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007491
Receipt number R000008827
Scientific Title Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.
Date of disclosure of the study information 2012/04/01
Last modified on 2014/01/07 17:20:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.

Acronym

PALODEX

Scientific Title

Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.

Scientific Title:Acronym

PALODEX

Region

Japan


Condition

Condition

patients with gynecological malignancies who are receiving paclitaxel/carboplatin.

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We evaluate the efficacy and tolerability of palonpsetron in combination with 1-day dexamethasone versus 3-day dexamethazone in patients with gynecologiccal malignancies who are receiving paclitaxel and carboplatin.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The primary endpoint is complete response(
no emetic episodes and no rescue medication) in delayed chemotherapy-induced nausea and vomiting.

Key secondary outcomes

The secondary endpoints are complete response in acute and overall chemotherapy-induced nausea and vomiting, and complete cntrol( no emetic episodes, no use of rescue medication, and no nausea), grade of nausea, and incidence of side effects in acute, delayed and overall chemotherapy-induced nausea and vomiting.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

day1 palonosetron0.75mg plus dexamethazone20mg
day2,3 dexametazone8mg

Interventions/Control_2

day1 palonosetron0.75mg plus dexamethazone20mg

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Gynecological malignacies confirmed by histology.
2.No previous history of receiving chemotherapy.
3.Receiving paclitaxel175mg/m2 plus carboplatin AUC=5.
4.Adequate bone marrow,liver,and renal functions.
5.Performance Status 0-1
6.written informed consent

Key exclusion criteria

1.Serious complication as followings; interstitial pneumonia; pulmonary fibrosis; heartfailure; renal failure; hepatic failure; uncontrolled diabetes mellitus etc.
2.Patients with symptomatic brain metastasis.
3.Receiving antiseizure medications.
4.Severe ascites and / or pleural effusion.
5.Bowel obstruction.
6.Symptom of emesis.
7.Hypersensitivity to have a history palonosetron and / or other 5-HT3 receptor antagonists.
8.Hypersensitivity to have a history dexamethazone.
9.Pregnancy or lactation.
10.Previous history of receiving palonosetron.
11.Inappropriate patients for this study judged by the physicians

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoto Furukawa

Organization

Nara Medical University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

840 Shijo-cho, Kashihara

TEL

0744-22-3051

Email



Public contact

Name of contact person

1st name
Middle name
Last name Naoto Furukawa

Organization

Nara Medical University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

840 Shijo-cho, Kashihara

TEL

0744-22-3051

Homepage URL


Email

furunao0813@gmail.com


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 02 Month 28 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2014 Year 01 Month 07 Day

Date of closure to data entry

2014 Year 01 Month 07 Day

Date trial data considered complete

2014 Year 01 Month 07 Day

Date analysis concluded

2014 Year 01 Month 07 Day


Other

Other related information



Management information

Registered date

2012 Year 03 Month 13 Day

Last modified on

2014 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008827


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name